GKWIM
TAK icon

Gerber Kawasaki Wealth & Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,420
Closed -$23K – 1003
2021
Q3 		$23K Buy
+1,420
New +$23.8K ﹤0.01% 473

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's TAK Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 1,420 shares — an estimated $23K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in TAK in Q3 2021 and held it in 1 quarter. The position peaked at $23K in Q3 2021. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1,420 Takeda Pharmaceutical shares in Q4 2021, an estimated $23K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Takeda Pharmaceutical position peaked at $23K in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.